D718-0895 Screening compound: N-(4-ACETAMIDOPHENYL)-2-{4-OXO-5-[(OXOLAN-2-YL)METHYL]-257-TRIAZATRICYCLO[6.4.0.0{26}]DODECA-1(8)6911-TETRAEN-3-YL}ACETAMIDE

D718-0895 Screening compound: N-(4-ACETAMIDOPHENYL)-2-{4-OXO-5-[(OXOLAN-2-YL)METHYL]-257-TRIAZATRICYCLO[6.4.0.0{26}]DODECA-1(8)6911-TETRAEN-3-YL}ACETAMIDE
D718-0895 Screening compound: N-(4-ACETAMIDOPHENYL)-2-{4-OXO-5-[(OXOLAN-2-YL)METHYL]-257-TRIAZATRICYCLO[6.4.0.0{26}]DODECA-1(8)6911-TETRAEN-3-YL}ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound D718-0895
N-(4-ACETAMIDOPHENYL)-2-{4-OXO-5-[(OXOLAN-2-YL)METHYL]-257-TRIAZATRICYCLO[6.4.0.0{26}]DODECA-1(8)6911-TETRAEN-3-YL}ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D718-0895

Molecular Formula

C24H25N5O4 (C24 H25 N5 O4)

Compound Name

N-(4-ACETAMIDOPHENYL)-2-{4-OXO-5-[(OXOLAN-2-YL)METHYL]-257-TRIAZATRICYCLO[6.4.0.0{26}]DODECA-1(8)6911-TETRAEN-3-YL}ACETAMIDE

IUPAC name

n/a

SMILES

CC(Nc(cc1)ccc1NC(CC(C(N1CC2OCCC2)=O)n2c1nc1c2cccc1)=O)=O

InChI

InChI=1S/C24H25N5O4/c1-15(30)25-16-8-10-17(11-9-16)26-22(31)13-21-23(32)28(14-18-5-4-12-33-18)24-27-19-6-2-3-7-20(19)29(21)24/h2-3,6-11,18,21H,4-5,12-14H2,1H3,(H,25,30)(H,26,31)

InChI Key

CQJSBZLDDNZZPK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD10479306

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.844

Distribution Coefficient, logD

1.837

Water Solubility, LogSw

-2.24

Polar Surface Area

81.204

Acid Dissociation Constant (pKa)

9.22

Base Dissociation Constant (pKb)

3.02

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

33.30

D718-0895 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

DGK Inhibitors Library (10558 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Proteases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D718-0895 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D718-0895?
Check Price and Availability of D718-0895, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D718-0895 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D718-0895
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D718-0895
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D718-0895 available by request